首页|茵栀黄口服液联合蓝光、头孢哌酮钠舒巴坦钠治疗新生儿感染性黄疸的临床疗效

茵栀黄口服液联合蓝光、头孢哌酮钠舒巴坦钠治疗新生儿感染性黄疸的临床疗效

扫码查看
目的:探讨茵栀黄口服液联合蓝光、头孢哌酮钠舒巴坦钠治疗新生儿感染性黄疸的临床疗效.方法:选取2021 年6 月至2023 年6 月杞县妇幼保健院收治的 94 例感染性黄疸新生儿作为研究对象,随机数字表法分为茵栀黄联合组和常规治疗组,各 47例.常规治疗组采用常规的蓝光照射和头孢哌酮钠舒巴坦钠抗感染治疗;茵栀黄联合组在常规治疗的基础上联合茵栀黄口服液治疗.治疗 7 d后,比较两组临床总有效率、黄疸消退时间、住院时间、胆红素下降值、神经行为能力[新生儿神经行为测定评分系统(Neonatal behavioral neurological assessment,NBNA)]、免疫球蛋白(Immunoglobulin,Ig)A、IgG水平、胆红素相关指标[血清白蛋白(Albumin,ALB)、非结合胆红素(Unconjugated bilirubin,UCB)、总胆红素(Total bilirubin,TBIL)水平]及不良反应发生率.结果:治疗后,茵栀黄联合组总有效率明显高于常规治疗组(P<0.05);茵栀黄联合组黄疸消退时间、住院时间明显短于常规治疗组,每日胆红素下降值明显大于常规治疗组(P<0.05);茵栀黄联合组血清IgA、IgG水平及NBNA评分均明显高于常规治疗组(P<0.05);茵栀黄联合组ALB、UCB、TBIL水平均明显低于常规治疗组(P<0.05);两组不良反应发生率无明显差异(P>0.05).结论:茵栀黄口服液联合蓝光、头孢哌酮钠舒巴坦钠治疗新生儿感染性黄疸疗效显著,可进一步缩短黄疸消退的时间,降低胆红素相关指标水平,提高患儿免疫功能和神经行为能力,加快患儿康复进程.
Clinical efficacy of Yinzhihuang oral liquid combined with blue light,cefoperazone sodium and sulbactam sodium in the treatment of neonatal infectious jaundice
Objective:To investigate the clinical efficacy of Yinzhihuang oral liquid combined with blue light,cefoperazone sodium and sulbactam sodium in the treatment of neonatal infectious jaundice.Methods:All 94 cases of infective jaundice neonates admitted to Qixian Maternal and Child Health Hospital from June 2021 to June 2023 were selected as the study object,and they were divided into Yinzhihuang combined group and conventional treatment group by random number table method,47 cases in each group.The conventional treatment group was treated with blue light irradiation,cefoperazone sodium and sulbactam sodium.Yinzhihuang combined group was treated with Yinzhihuang oral liquid on the basis of conventional treatment group.After 7 days of treatment,the total clinical response rate,jaundice resolution time,length of hospital stay,bilirubin decline,neurobehavioral ability neonatal behavioral neurological assessment(NBNA),Immunoglobulin(Ig)A,IgG levels,bilirubin-related indexes albumin(ALB),unconjugated bilirubin(UCB),total bilirubin(TBIL)level and the incidence of adverse reactions were compared between the two groups.Results:After treatment,the total effective rate of Yinzhihuang combined group was significantly higher than that of conventional treatment group(P<0.05).jaundice resolution time and length of hospital stay in Yinzhihuang combined group were significantly shorter than those in conventional treatment group,and the daily reduction value of bilirubin was significantly greater than that in conventional treatment group(P<0.05).The serum levels of IgA and IgG,NBNA scores in Yinzhihuang combined group were significantly higher than those in conventional treatment group(P<0.05).The levels of ALB,UCB and TBIL in Yinzhihuang combined group were significantly lower than those in conventional treatment group(P<0.05);there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Yinzhihuang oral liquid combined with blue light,cefoperazone sodium and sulbactam sodium is effective in the treatment of neonatal infectious jaundice,which can further shorten the time of jaundice resolution,reduce the level of related indexes of bilirubin,improve the immune function and neurobehavioral ability of children,and accelerate the rehabilitation process of children.

Neonatal infectious jaundiceYinzhihuang oral liquidBlue light exposureCefoperazone sodium and sulbactam sodium

李肖霞、高杰、王雪芹

展开 >

杞县妇幼保健院新生儿科,河南 开封 475000

开封市淮河医院新生儿科,河南 开封 475000

开封市儿童医院新生儿科,河南 开封 475000

新生儿感染性黄疸 茵栀黄口服液 蓝光照射 头孢哌酮钠舒巴坦钠

河南省医学科技攻关联合共建项目

LHGJ20212001

2024

四川生理科学杂志
四川省生理科学会

四川生理科学杂志

影响因子:0.575
ISSN:1671-3885
年,卷(期):2024.46(7)